Perbak Capital Partners’s CVS Health CVS Stock Holding History

Perbak Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,078	Closed	-$1.44M	–	72
2026 Q1	$1.44M	Buy	+20,078	New	+$1.55M	0.35%	32

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Perbak Capital Partners's CVS Position: Q2 2026 in Review

Perbak Capital Partners sold out of CVS Health (CVS) in Q2 2026, closing a stake of 20,078 shares — an estimated $1.44M sold.

Perbak Capital Partners first reported a position in CVS in Q1 2026 and held it in 1 quarter. The position peaked at $1.44M in Q1 2026. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Perbak Capital Partners reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Perbak Capital Partners sold 20,078 CVS Health shares in Q2 2026, an estimated $1.44M.
Perbak Capital Partners first reported a position in CVS Health in Q1 2026 and held it in 1 quarter.
Perbak Capital Partners's CVS Health position peaked at $1.44M in Q1 2026.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.